Cruxx announced its second FDA Breakthrough Device Designation for Brain Interchange™, which is now designated for stroke motor rehabilitation and communication for non-progressive quadriplegia.

Cruxx places MedTech pioneers in transformative roles, to help us live longer, healthier lives. We connect visionary talent with leading companies shaping the future of healthcare innovation. We focus on placing leadership and innovators who are ready to push the boundaries of medical technology and help turn today’s ideas into tomorrow’s life-changing realities. At Cruxx, we don’t just find talent—we solve problems. We are changemakers, We are Purposeful, We are Impactful and We are relentless in our pursuit This is Cruxx.